N-(4-Hydroxyphenyl)retinamide-induced death in human lymphoblastoid cells: 50 kb DNA breakage as a means of distinguishing apoptosis from necrosis

Cancer Letters

Volumn 128, Issue 2, 1998, Pages 189-196

  Springer, Lisa N ^a   Stewart, Bernard W ^a  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

Author keywords

Apoptosis; Lymphoblastoid cell; N (4 Hydroxyphenyl)retinamide; Pulsed field electrophoresis

Indexed keywords

DNA FRAGMENT; FENRETINIDE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CHEMOPROPHYLAXIS; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; T LYMPHOBLAST;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DNA DAMAGE; DNA, NEOPLASM; FENRETINIDE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, T-CELL; NECROSIS;

EID: 0032547034     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00071-8     Document Type: Article

References (31)

1. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 10:1993;1031-1039.
2. R. Sankaranarayanan, B. Mathew, Retinoids as cancer-preventive agents, in: B.W. Stewart, D. McGregor, P. Kleihues (Eds.), Principles of Chemoprevention, IARC, Lyon, 1996, pp. 47-59.
3. Boone C.W., Kelloff G.J., Malone W.F. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res. 50:1990;2-9.
4. Kazmi S.M.I., Plante R.K., Visconti V., Lau C.Y. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res. 56:1996;1056-1062.
5. Lotan R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst. 87:1995;1655-1657.
6. Costa A., Formelli F., Chiesa F., Decensi A., De Palo G., Veronesi U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res. 54:1994;2032-2037.
7. Formelli F., Clerici M., Campa T., Di Mauro G.M., Magni A., Mascotti G., Moglia D., De Palo G., Costa A., Veronesi U. Five year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J. Clin. Oncol. 11:1993;2036-2042.
8. Pienta K.J., Nguyen N.M., Lehr J.E. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res. 53:1993;224-226.
9. Moon R.C., Thompson H.J., Beeci P.J., Grubbs C.J., Gander R.J., Newton D.L., Smith J.M., Phillips S.L., Henderson W.R., Mullen L.T., Brown C.C., Sporn M.B. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 39:1979;1339-1346.
10. Mariotti A., Marcora E., Bunone G., Costa A., Veronesi U., Pierotti M.A., Valle G.D. N-(4-Hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst. 86:1994;1245-1247.
11. Ponzoni M., Bocca P., Chiesa V., Decensi A., Pistoia V., Raffaghello L., Rozzo C., Montaldo P.G. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res. 55:1995;853-861.
12. Di Vinci A., Geido E., Infusini E., Giaretti W. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Int. J. Cancer. 59:1994;422-426.
13. Wang T.Y., Phang J.M. Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells. Cancer Lett. 107:1996;65-71.
14. Solary E., Bertrand R., Kohn K.W., Pommier Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood. 81:1993;1359-1368.
15. Delia D., Aiello A., Lombardi L., Pelicci P.G., Grignani F., Formelli F., Menard S., Costa A., Veronesi U., Pierotti M.A. N-(4-Hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res. 53:1993;6036-6041.
16. Kohn K.W., Jackman J., O'Connor P.M. Cell cycle control and cancer chemotherapy. J. Cell Biol. 54:1994;440-452.
17. Bortner C.D., Oldenburg N.B.E., Cidlowski J.A. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 5:1995;21-26.
18. Cohen G.M., Sun X.M., Fearnhead H., MacFarlane M., Brown D.G., Snowden R.T., Dinsdale D. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J. Immunol. 153:1994;507-516.
19. Catchpoole D.R., Stewart B.W. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res. 53:1993;4287-4296.
20. Deitch A.D., Law H., White R.D. A stable propidium iodide staining procedure for flow cytometry. J. Histochem. Cytochem. 30:1982;967-972.
21. Catchpoole D.R., Stewart B.W. Formation of apoptotic bodies is associated with internucleosomal DNA fragmentation during drug-induced apoptosis. Exp. Cell Res. 215:1995;169-177.
22. Sleiman R.J., Catchpoole D.R., Stewart B.W. Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism. Br. J. Cancer. 77:1998;40-50.
23. Springer L.N., McAsey M.E., Flaws J.A., Tilly J.L., Sipes I.G., Hoyer P.B. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol. Appl. Pharmacol. 139:1996;394-401.
24. Kalemkerian G.P., Slusher R., Ramalingam S., Gadgeel S., Mabry M. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J. Natl. Cancer Inst. 87:1995;1674-1680.
25. Supino R., Crosti M., Clerici M., Walters A., Cleris L., Zunino F., Formelli F. Induction of apoptosis by fenretinide (4-HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int. J. Cancer. 65:1996;491-497.
26. Roberson K.M., Penland S.N., Padilla G.M., Selvan R.S., Kim C.-S., Fine R.L., Robertson C.N. Fenretinide: induction of apoptosis and endogenous transforming growth factor-β in PC-3 prostate cancer cells. Cell Growth Diff. 8:1997;101-111.
27. Piacentini M., Fesus L., Melino G. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Lett. 320:1993;150-154.
28. Anilkumar T.V., Sarraf C.E., Hunt T., Alison M.R. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br. J. Cancer. 65:1992;552-558.
29. Huschtascha L.I., Bartier W.A., Andersson Ross C.E., Tattersall M.H.N. Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br. J. Cancer. 73:1996;54-60.
30. Corcoran G.B., Fix L., Jones D.P., Moslen M.T., Nicotera P., Oberhammer F.A., Buttyan R. Contemporary issues in toxicology. Apoptosis: molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128:1994;169-181.
31. Evan G.I., Wyllie A.H., Gilbert S.C., Littlewood T.D., Land H., Brooks M., Waters C., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.